A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients with Early Stage Breast Cancer
- 1 September 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 11 (9), 846-853
- https://doi.org/10.1245/aso.2004.11.033
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Determinants of Diagnostic Performance Of [F-18]Fluorodeoxyglucose Positron Emission Tomography for Axillary Staging in Breast CancerAnnals of Surgery, 2002
- Positron Emission Tomography and Sentinel Lymph Node Dissection in Breast CancerClinical Breast Cancer, 2002
- Comparison of Attenuation-corrected and Non-corrected FDG-PET Images for Axillary Nodal Staging in Newly Diagnosed Breast CancerMolecular Imaging & Biology, 2002
- Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissectionBritish Journal of Surgery, 2001
- Positron emission tomography in breast cancer: a clinicopathological correlation of results.The British Journal of Radiology, 1999
- Clinical PET in OncologyClinical Positron Imaging, 1998
- Staging of the Axilla in Breast CancerAnnals of Surgery, 1998
- Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage i. results from a randomised trialEuropean Journal of Cancer, 1997
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Users' Guides to the Medical LiteratureJAMA, 1994